Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 56Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Follicular 48Lymphoma 47Leukemia, Lymphocytic, Chronic, B-Cell 45Lymphoma, Mantle-Cell 41Lymphoma, B-Cell, Marginal Zone 24Lymphoma, B-Cell 22Waldenstrom Macroglobulinemia 17Hodgkin Disease 16Burkitt Lymphoma 16Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Recurrence 10Lymphoma, Large-Cell, Immunoblastic 9Neoplasms 7Multiple Myeloma 6Myelodysplastic Syndromes 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Hairy Cell 4Intraocular Lymphoma 4Hematologic Neoplasms 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell 3Lymphoma, Primary Effusion 3Immunoblastic Lymphadenopathy 3

Interventions

pevonedistat 1Vincristine 1Rituximab 1Prednisone 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Acromesomelic dysplasia, Maroteaux type × Rituximab × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡